138 related articles for article (PubMed ID: 30944538)
1. Preparation, characterization, and
Zhu X; Xu S; Lu L; Wang S; Zhao Q; Li D; Li J; Zhao H; Xu B
J Vet Sci; 2019 Mar; 20(2):e16. PubMed ID: 30944538
[TBL] [Abstract][Full Text] [Related]
2. Preparation of valnemulin hydrogen fumarate and its enhanced stability compared with valnemulin hydrochloride.
Zhu X; Xu S; Xu Q
Pharm Dev Technol; 2016; 21(3):338-45. PubMed ID: 25597619
[TBL] [Abstract][Full Text] [Related]
3. Characterization and In vivo Evaluation of Polymorphic Valnemulin Hydrogen Fumarate.
Xinle Z; Li Z; Jian L; Hui Z; Jinhua G; Hejia W
Curr Drug Deliv; 2024 Jun; ():. PubMed ID: 38847258
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization, and pharmacokinetics in swine of a florfenicol enteric formulation prepared using hot-melt extrusion technology.
Xu Y; Wen X; Feng X; Liang Z; Ye X; Nie H; Liao X; Li J; Zeng Y; Tang S; He J
J Vet Pharmacol Ther; 2018 Aug; 41(4):572-580. PubMed ID: 29500829
[TBL] [Abstract][Full Text] [Related]
5. Characterization of two polymorphs of lornoxicam.
Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S
J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
[TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of azithromycin--Aerosil 200 solid dispersions with enhanced physical stability.
Li X; Peng H; Tian B; Gou J; Yao Q; Tao X; He H; Zhang Y; Tang X; Cai C
Int J Pharm; 2015; 486(1-2):175-84. PubMed ID: 25794608
[TBL] [Abstract][Full Text] [Related]
8. Preparation and Evaluation of Valnemulin Hydrochloride Taste-Masking Granules.
Liang Y; Hu D; Yan Y; Chen D; Xie S
Curr Drug Deliv; 2022; 19(3):337-346. PubMed ID: 34477518
[TBL] [Abstract][Full Text] [Related]
9. Solid-state supramolecular synthesis based on the N-H…O heterosynthon: an approach to solve the polymorphism problem in famotidine.
Russo MG; Brusau EV; Ellena J; Narda GE
J Pharm Sci; 2014 Nov; 103(11):3754-3763. PubMed ID: 25277273
[TBL] [Abstract][Full Text] [Related]
10. Combined Atomistic Molecular Calculations and Experimental Investigations for the Architecture, Screening, Optimization, and Characterization of Pyrazinamide Containing Oral Film Formulations for Tuberculosis Management.
Adeleke OA; Monama NO; Tsai PC; Sithole HM; Michniak-Kohn BB
Mol Pharm; 2016 Feb; 13(2):456-71. PubMed ID: 26650101
[TBL] [Abstract][Full Text] [Related]
11. Studies on the crystal forms of pefloxacin: preparation, characterization, and dissolution profile.
Yadav MR; Shaikh AR; Ganesan V; Giridhar R; Chadha R
J Pharm Sci; 2008 Jul; 97(7):2637-48. PubMed ID: 17854073
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of metastable solid-state forms of lopinavir.
Lemmer HJ; Liebenberg W
Pharmazie; 2013 May; 68(5):327-32. PubMed ID: 23802429
[TBL] [Abstract][Full Text] [Related]
13. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
[TBL] [Abstract][Full Text] [Related]
14. Characterization of polymorphic ampicillin forms.
Baraldi C; Tinti A; Ottani S; Gamberini MC
J Pharm Biomed Anal; 2014 Nov; 100():329-340. PubMed ID: 25194347
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the solubility and solid-state properties of saccharin salts of fluoroquinolones.
Romañuk CB; Manzo RH; Linck YG; Chattah AK; Monti GA; Olivera ME
J Pharm Sci; 2009 Oct; 98(10):3788-801. PubMed ID: 19226631
[TBL] [Abstract][Full Text] [Related]
16. The characterization and comparison of spray-dried mannitol samples.
Hulse WL; Forbes RT; Bonner MC; Getrost M
Drug Dev Ind Pharm; 2009 Jun; 35(6):712-8. PubMed ID: 19514986
[TBL] [Abstract][Full Text] [Related]
17. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
[TBL] [Abstract][Full Text] [Related]
18. Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach.
Karimi K; Pallagi E; Szabó-Révész P; Csóka I; Ambrus R
Drug Des Devel Ther; 2016; 10():3331-3343. PubMed ID: 27784991
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
Tao T; Zhao Y; Wu J; Zhou B
Int J Pharm; 2009 Feb; 367(1-2):109-14. PubMed ID: 18930795
[TBL] [Abstract][Full Text] [Related]
20. Solid-state characterization of novel active pharmaceutical ingredients: cocrystal of a salbutamol hemiadipate salt with adipic acid (2:1:1) and salbutamol hemisuccinate salt.
Paluch KJ; Tajber L; Elcoate CJ; Corrigan OI; Lawrence SE; Healy AM
J Pharm Sci; 2011 Aug; 100(8):3268-3283. PubMed ID: 21472730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
